93 related articles for article (PubMed ID: 4582276)
1. [Fibrinogen--interpretation of the test results].
Yamada S; Izuchi Y; Miyanishi E; Kusunose K
Nihon Rinsho; 1973; 31():1705-12. PubMed ID: 4582276
[No Abstract] [Full Text] [Related]
2. [Determination of fibrinogen].
Yamada S; Izuchi Y; Miyanishi E; Kusunose K
Nihon Rinsho; 1976; 34 suppl():2380-9. PubMed ID: 792516
[No Abstract] [Full Text] [Related]
3. [Fibrinogen: interpretation of the test results].
Yamada S; Miyanishi E; Izuchi Y
Nihon Rinsho; 1969 Mar; ():Suppl:1012-20. PubMed ID: 4948287
[No Abstract] [Full Text] [Related]
4. Studies on the hemorheological factors in ischemic heart disease and cerebrovascular disorders.
Fukuda I; Yoshida T; Yoritsune H; Kiso T; Konishi S; Kawasaki T; Mozai T
Bull Osaka Med Sch; 1978 Oct; 24(2):83-91. PubMed ID: 757138
[No Abstract] [Full Text] [Related]
5. [Various clinico-biochemical comparisons in ischemic stroke (a study of the fibrinogen of fibrinolysis)].
Karpinskaia VM; Zaretskaia IKh
Klin Med (Mosk); 1968 May; 46(5):109-16. PubMed ID: 5669570
[No Abstract] [Full Text] [Related]
6. [When will fibrinogen screening become available?].
Ernst E
Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
[No Abstract] [Full Text] [Related]
7. [Fibrinogen--how to read its figures].
Yamada S; Miyanishi E; Izuchi Y
Nihon Rinsho; 1971 Jan; 29():Suppl:568-76. PubMed ID: 4929701
[No Abstract] [Full Text] [Related]
8. [Parameters of blood clotting and fibrinolysis in patients with acute cerebrovascular diseases].
Pryszmont M; Myśliwiec M
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1975; 20():217-22. PubMed ID: 815988
[No Abstract] [Full Text] [Related]
9. [Fibrinogen: a risk factor].
Potron G; N'Guyen P; Pignon B
J Mal Vasc; 1996; 21(3):126-32. PubMed ID: 8965039
[TBL] [Abstract][Full Text] [Related]
10. [A simple test system for the classification of hemorrhagic syndromes (with 2 new, simple test methods)].
Schmidt-Matthiesen H; Johannssen H
Geburtshilfe Frauenheilkd; 1966 Aug; 26(8):1165-72. PubMed ID: 5990261
[No Abstract] [Full Text] [Related]
11. [Characteristics of the dynamics of the fibrinogen level and the fibrinolysis indices in the blood of the human coronary bed].
Chazov EI; Andreenko GV; Liutova LV; Podol'skaia LV; Sargin KE
Klin Med (Mosk); 1972 Dec; 50(12):24-9. PubMed ID: 4660498
[No Abstract] [Full Text] [Related]
12. [Comparison of the results of the Brdicka reaction with fibrinogen level and fibrinolysis of plasma euglubolins for the diagnosis of malignant neoplasms].
Kosmala U; Niewiadomska S; Plamieniak Z
Pol Tyg Lek; 1969 Jul; 24(29):1112-5. PubMed ID: 5808598
[No Abstract] [Full Text] [Related]
13. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G
Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612
[TBL] [Abstract][Full Text] [Related]
14. [Status of the blood clotting system in stroke (review of the Soviet and foreign literature)].
Martynov FI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1400-5. PubMed ID: 7034425
[No Abstract] [Full Text] [Related]
15. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia.
Pola P; Flore R; Tondi P
Int J Tissue React; 1986; 8(4):333-6. PubMed ID: 2943690
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor of coronary heart disease. II. Changes of platelets, fibrinogen and antiplasmins in a group of 2,000 middle aged men (40-60 years) periodically followed up for three years.
Papilian M; Niţă I
Med Interne; 1975; 13(4):271-82. PubMed ID: 128813
[No Abstract] [Full Text] [Related]
17. Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs.
Warlow CP; Rennie JA; Ogston D; Douglas AS
Thromb Haemost; 1976 Aug; 36(1):127-32. PubMed ID: 1036801
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen and coronary heart disease--what does it mean?
Oliver MF
Eur Heart J; 1998 Jan; 19(1):8-9. PubMed ID: 9503169
[No Abstract] [Full Text] [Related]
19. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
[TBL] [Abstract][Full Text] [Related]
20. [Fibrinogen Magdeburg--a new hereditary dysfibrinogen].
Lutze G; Urbahn H
Z Med Lab Diagn; 1987; 28(7):378-84. PubMed ID: 3433890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
